VistaGen Therapeutics, Inc.
- VTGN
- NASDAQ
- Biotechnology
- CNS Drug Development
- Anxiety/Depression Treatments
$0.20
Today +1.55%Quote Oct 19, 2026, 08:00 PM UTC
−15.37%over the last month
Max drawdown −45.7%From 1-month high −44.9%3 months −13.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About VistaGen Therapeutics
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical entity dedicated to advancing and commercializing innovative medications for anxiety, depression, and various other disorders impacting the central nervous system (CNS).
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
41
Founded
1998
Market value
$9.0M
Quote Oct 19
Floor
$0.20
2.5% below price
Resistance
$0.21
4.0% above price
Price vs analyst targets
7 analysts
Lowest target
$0.90Highest target
$1.00
$0.90Highest target
$1.00
- Price $0.20
- Average target $0.95
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 368% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about VTGNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free